- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Listening is the Key to Good Leadership
HBA mentor of the year and director of U.S. public affairs for AbbVie, Jag Dosanjh, divulges in this Pharm Exec Podcast his approach to leadership and how: “If you listen well, you can learn well.”
We all know that the pharma industry is about people—bettering the lives of others through good research, life-changing pharmaceuticals, and keeping the patient front and center. But Jag Dosanjh, president of US neuroscience and eye care, AbbVie, lives that principle. In this podcast episode, Meg Rivers, managing editor, talks with Dosanjh about what he calls a “people business” and his approach to leadership. He starts his career in the medical sales space before working in many different roles and therapeutic areas before ultimately landing at AbbVie. He was also nominated HBA’s mentor of the year and shares insights into being a good leader and mentor. One of his tips was: “If you listen well, you can learn well.” In addition, he emphasized the importance of curiosity, learning, and the pursuit of a smile.
About the speaker
Jag Dosanjh is the president of US neuroscience and eye care, AbbVie, where he is responsible for leading the business and represents a strong portfolio of major brands across many different disease areas. Dosanjh joined AbbVie in 2011 and served in a variety of business leadership roles in addition to leading the U.S. market access and global strategic marketing functions. Most recently, he served as senior vice president of medical therapeutics, overseeing BOTOX therapeutic and eye care. Prior to this, Dosanjh worked at GlaxoSmithKline for more than 15 years in several executive positions in both European, U.S., and global roles with key areas of focus being vaccine biologicals and respiratory medicine. Dosanjh holds a BA (Hons) degree in business studies from Sheffield Hallam University in the UK.
About the Pharm Exec Podcast
The editors of Pharmaceutical Executive bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
